Literature DB >> 24565716

The safety or risk of antihistamine use in pregnancy: reassuring data are helpful but not sufficient.

Margaret A Honein1, Cynthia A Moore2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24565716      PMCID： PMC4559231          DOI： 10.1016/j.jaip.2013.08.005

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  12 in total

1.  Asthma medication use in pregnancy and fetal growth.

Authors:  Ludmila N Bakhireva; Kenneth Lyons Jones; Michael Schatz; Diana Johnson; Christina D Chambers
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

2.  The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy.

Authors:  Patrick W Sullivan; Kavita V Nair; Bimal V Patel
Journal:  Am J Manag Care       Date:  2005-06       Impact factor: 2.229

3.  Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine.

Authors:  Cliona Cummings; Moira Stewart; Mike Stevenson; Jim Morrow; Joanne Nelson
Journal:  Arch Dis Child       Date:  2011-03-17       Impact factor: 3.791

4.  Nausea and vomiting during pregnancy: A prospective study of its frequency, intensity, and patterns of change.

Authors:  R Lacroix; E Eason; R Melzack
Journal:  Am J Obstet Gynecol       Date:  2000-04       Impact factor: 8.661

5.  Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.

Authors:  Jakob Christensen; Therese Koops Grønborg; Merete Juul Sørensen; Diana Schendel; Erik Thorlund Parner; Lars Henning Pedersen; Mogens Vestergaard
Journal:  JAMA       Date:  2013-04-24       Impact factor: 56.272

Review 6.  Nausea and vomiting of pregnancy.

Authors:  Jeffrey D Quinla; D Ashley Hill
Journal:  Am Fam Physician       Date:  2003-07-01       Impact factor: 3.292

7.  Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011.

Authors:  Stacey L Peters; Jennifer N Lind; Jasmine R Humphrey; Jan M Friedman; Margaret A Honein; Melissa S Tassinari; Cynthia A Moore; Lisa L Mathis; Cheryl S Broussard
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-01-29       Impact factor: 2.890

Review 8.  Management of epilepsy during pregnancy.

Authors:  Dina Battino; Torbjörn Tomson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk.

Authors:  Phoebe G Thorpe; Suzanne M Gilboa; Sonia Hernandez-Diaz; Jennifer Lind; Janet D Cragan; Gerald Briggs; Sandra Kweder; Jan M Friedman; Allen A Mitchell; Margaret A Honein
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-07-29       Impact factor: 2.890

10.  Use of antihistamine medications during early pregnancy and isolated major malformations.

Authors:  Suzanne M Gilboa; Matthew J Strickland; Andrew F Olshan; Martha M Werler; Adolfo Correa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-02
View more
  1 in total

Review 1.  Antihistamines and birth defects: a systematic review of the literature.

Authors:  Suzanne M Gilboa; Elizabeth C Ailes; Ramona P Rai; Jaynia A Anderson; Margaret A Honein
Journal:  Expert Opin Drug Saf       Date:  2014-10-11       Impact factor: 4.250
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.